Prognostic and Therapeutic Value of LSM5 Gene in Human Brain Cancer Glioma: An Omics Database Exploration Approach-Reference-Cited by-同舟云学术

Prognostic and Therapeutic Value of LSM5 Gene in Human Brain Cancer Glioma: An Omics Database Exploration Approach

Published:2022-09-09 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Ullah Md. Asad¹,Alam Sayka¹,Farzana Maisha²,Moin Abu Tayab³,Prapty Chowdhury Nusaiba Binte Sayed²,Zohora Umme Salma¹,Rahman Mohammad Shahedur¹

Affiliation:

1. Jahangirnagar University

2. BRAC University

3. University of Chittagong

Abstract

Abstract • This study explored the clinical relevance of LSM5 gene in glioma diagnosis and treatment for the first time • LSM5 is overexpressed in lower-grade glioma (LGG) and glioblastoma multiforme (GBM) tissues • The promoter of LSM5 gene is differentially methylated in both LGG and GBM tissues • The expression of LSM5 correlates with the survival condition and immunophenotypes of glioma patients

Publisher

Research Square Platform LLC

Reference69 articles.

1. Glial tumor invasion: a role for the upregulation and cleavage of BEHAB/brevican;Nutt CL;The Neuroscientist,2001

2. Glioma subclassifications and their clinical significance;Chen R;Neurotherapeutics,2017

3. Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GR, Fitzek MM, Chiocca EA, Rabinov JD, Csavoy AN, Rosen BR. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendroglimoas. American Journal of Neuroradiology. 2004 Feb 1;25(2):214 – 21.

4. Pollack IF. Brain tumors in children. New England Journal of Medicine. 1994 Dec 1;331(22):1500-7.

5. Malignant gliomas in adults;Wen PY;New England Journal of Medicine. 2008 Jul